Oncology News

ESMO oncology news ensures that you're always kept up to date with the latest developments that affect you and your daily practice. Make sure you check these pages frequently, or sign up to our newsletter.

Filter

Date Title Topic
04 Feb 2015 ESMO Press Release: Making Equal Access to Cancer Treatment A Priority Bioethics, legal and economic issues
03 Feb 2015 Large Study Catalogues Genetic Alterations in Head and Neck Squamous Cell Carcinomas Translational research - Head and neck cancers
02 Feb 2015 FDA Expands Approved Use of Ibrutinib to Waldenström’s Macroglobulinaemia Haematologic malignancies - Anticancer agents & Biologic therapy
30 Jan 2015 First Major Analysis of Human Protein Atlas Translational research
29 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Ruxolitinib Haematologic malignancies - Anticancer agents & Biologic therapy
28 Jan 2015 Withdrawal of the Application for a Change to the Marketing Authorisation for Tegafur/Gimeracil/Oteracil Gastrointestinal cancers - Anticancer agents & Biologic therapy
27 Jan 2015 A New Study Links XRCC2 Mutations to Cisplatin Resistance in Testicular Cancer Genitourinary cancers - Translational research
27 Jan 2015 Annals of Oncology Press Release: Lung Cancer Predicted to Overtake Breast Cancer as Leading Cause of Cancer Death Among European Women in 2015 Lung and other thoracic tumours
26 Jan 2015 ESMO Press Release: ESMO Delivers on Dynamic Force Strategy to Improve Cancer Research in Europe Bioethics, legal and economic issues
26 Jan 2015 European Medicines Agency Recommends a Variation to the Terms of the Marketing Authorisation for Protein Bound Paclitaxel Lung and other thoracic tumours - Anticancer agents & Biologic therapy
22 Jan 2015 Successful Implementation of SPECTAcolor, the First Pan-European and EORTC Screening Platform, Proves that a Logistically Complex Infrastructure to Run Next Generation Trials in a Multinational Setting is Feasible Personalised medicine - Translational research - Gastrointestinal cancers
20 Jan 2015 First-Line FOLFOXIRI/Bevacizumab Improves Long-Term Outcomes in Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
19 Jan 2015 Second-Line Treatment with FOLFIRI/Ramucirumab Delays Disease Progression and Extends Overall Survival in Patients With Metastatic Colorectal Cancer Gastrointestinal cancers - Anticancer agents & Biologic therapy
16 Jan 2015 Next Generation Sequencing Reveals Genetic Landscape of Breast Phyllodes Tumours Breast cancer - Translational research
14 Jan 2015 Many Cancer Survivors Have Unmet Physical and Mental Needs Palliative and supportive care